Clinical Trials Directory

Trials / Completed

CompletedNCT02073071

Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weight Infants

Status
Completed
Phase
Study type
Observational
Enrollment
139 (actual)
Sponsor
Abbott Nutrition · Industry
Sex
All
Age
21 Days
Healthy volunteers
Not accepted

Summary

This is a two stage open-label, single-arm, multicenter and observational study.

Detailed description

Stage 1: In hospital, preterm/low birth weight infants less than or equal to 34 weeks gestational age at birth, birth weight of ≥ 1000g to \<1800g and conditions meeting the enrollment criteria will be fed formula with or without parenteral nutrition until discharge. Stage 2: Post-discharge, all infants with birth weight \< or =1500g will be followed on formula per standard of care and accepted standard of care including feeding until the infant's weight \>or= 25th percentile of growth expectation based on corrected age (P25) or until infant reaches 9 months corrected age.

Conditions

Interventions

TypeNameDescription
OTHERPreterm infant formula per standard of careCommercially available preterm infant formula

Timeline

Start date
2014-05-01
Primary completion
2015-09-01
Completion
2015-11-01
First posted
2014-02-27
Last updated
2015-11-30

Locations

10 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02073071. Inclusion in this directory is not an endorsement.